Clinical trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression

Janssen Research & Development, LLCCompletedPhase 3Started Aug 20, 2015139 enrolledUnited States, Belgium, Brazil, Bulgaria, Finland, France, Lithuania, Poland, South Africa, Spain, Sweden, United KingdomNCT02422186

Abstract

The purpose of this study is to evaluate the efficacy and safety of switching elderly participants with treatment-resistant depression (TRD) from a prior antidepressant treatment (to which they have not responded) to either intranasal esketamine plus a new oral antidepressant or switching to a new oral antidepressant plus intranasal placebo.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Depressive Disorder, Treatment-ResistantEsketamineOral AntidepressantElderly ParticipantsDepressive Disorder, Treatment-Resistant

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.